WEALTH ENHANCEMENT ADVISORY SERVICES, LLC

Position in OPK — Opko Health, Inc.

CIK 1632972 PLYMOUTH, MN

Position in OPK

as of Jun 30, 2026 · filed Jul 15, 2026 Compact

Position Value

$125,991

+$54,895 QoQ

Shares Held

83,994

+34.7% QoQ

Ownership

0.011%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

of 21 holders

Holding Since

Sep 2023

10 quarters on record

Voting authority Sole 1.4405790889825463.ToString("F0")% Shared 0.ToString("F0")% None 98.55942091101745.ToString("F0")%

Healthcare · as of Jun 30, 2026

WEALTH ENHANCEMENT ADVISORY SERVICES, LLC holds $184,108,370 across 28 Diagnostics & Research names. OPK ranks #28 (0.1% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	TMO	Thermo Fisher Scientific Inc.	93,673	$46,963,895
2	DHR	Danaher Corp /De/	139,461	$26,564,531
3	ILMN	Illumina, Inc.	107,790	$18,952,715
4	LH	Labcorp Holdings Inc.	56,094	$15,706,320
5	NTRA	Natera, Inc.	55,459	$15,054,345
6	A	Agilent Technologies, Inc.	103,978	$13,811,397
7	MEDP	Medpace Holdings, Inc.	15,922	$8,432,131
8	IQV	Iqvia Holdings Inc.	42,028	$8,120,650

10 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$125,991	83,994	+34.7%	Shares	Sole	2026-07-15
2026-03-31	$71,096	62,365	+8.4%	Shares	Sole	2026-04-08
2025-12-31	$72,486	57,529	-24.1%	Shares	Sole	2026-01-08
2025-09-30	$117,410	75,749	+104.8%	Shares	Sole	2025-10-29
2025-06-30	$48,832	36,994	-50.5%	Shares	Sole	2025-07-10
2025-03-31	$124,011	74,706	+158.4%	Shares	Sole	2025-04-16
2024-12-31	$42,494	28,908	+75.3%	Shares	Sole	2025-03-17
2024-09-30	$24,571	16,491	-1.1%	Shares	Sole	2024-10-24
2024-06-30	$20,838	16,671	+52.0%	Shares	Sole	2024-07-16
2023-09-30	$17,550	10,969	—	Shares	Sole	2023-11-13
No filing history on record for this holder in this stock.